Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
ONT

Oxford Nanopore Technologies plc

ONTLSEUnited KingdomHealthcareBiotechnologyFTSE 250

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for…more

P/B4.83xROIC-37.9%
£2.06B
Market Cap
EV: £1.86B
MOM3
QUAL4
VAL0
RSK5
ONT
£2.06B
Market Cap · EV £1.86B

Oxford Nanopore Technologies plc

MOM3
QUAL4
VAL0
RSK5

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for…more

Latest RNS from Oxford Nanopore Technologies plc

Analyst consensus: Buy

As of 10 Nov 2026, 12 analysts rate Oxford Nanopore Technologies plc a Buy, with 83% buy ratings and a mean price target of 217p (range 135p–300p), +4% vs the current price.

Strong buy: 4Buy: 6Hold: 2Sell: 0Strong sell: 0

Full analyst history →

More Healthcare companies